Jeff Guo

Atzinger CB, Guo JJ 2017. Biologic disease-modifying antirheumatic drugs in a nation, privately insured population: utilization, expenditures, and price trends. Am Health Drug Benefit., 10 1, 27

Xu X, Rao Y, Abdullah AS, Sharma M, Guo JJ 2017. Preventive behaviors in avoiding indoor secondhand smoke exposure among pregnant women in China BMJ Tobacco Control, 26 4, 483

Almalki ZS, Alahmari AK, Guo JJ, Cavanaugh TM 2016. Off-Label Use of Oral Fluoroquinolone Antibiotics in Outpatient Settings in the United States, 2006 to 2012 Pharmacoepi Drug Safety , 25 9, 1042

Gailling B, Roldan A, Nielsen RE, Nielsen J, Gerhard T, Guo JJ, et al. 2016. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: a systematic review and meta-analysis. JAMA Psychiatry , 73 3, 247

Guo JJ*, Chen Y, Du WM, Wigle PR, Papadimitropoulos EA 2016. Antithrombotic therapy and direct medical costs in patients with acute coronary syndrome Value in Health RI , 9 c, 93

Xia Y, Kelton CML, Wigle PR, Heaton P, Guo JJ**. 2016. Twenty Yeas of Triptans in the United States Medicaid Programs: utilization and reimbursement trends from 1993 to 2013 Cephalalgia, 36 14, 1305

Guo JJ, Lei J, Xia Y, Yue X 2015. Use of health databases for Pharmacoepidemiology and drug safety in therapeutic risk management. Chinese J Pharmacoepidemiology , 24 2, 83-

Xia Y, Kelton CML, Guo JJ, Bian B, Heaton PC. 2015. Treatment of obesity: pharmacotherapy trends in the United States from 1999 to 2010. Obesity, 23 8, 1721

Zhong GC, Wang Y, Zhang Y, Guo JJ 2015. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLOS ONE, 10 3, e0118333.

Almalki ZS, Guo JJ. 2014. Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials Am Health Drug Benefit, 7 6, 318

Kelton CML, Guo JJ, Yu Y, Berry EA, Bian B, Heaton PC. 2014. Firm- and Drug-Specific Patterns of Generic Drug Payments by U.S. Medicaid Programs: 1991-2008. Applied Health Economics Health Policy, 12 , 165–

Berry EA, Kelton CM, Guo JJ, Heaton PC. 2013. Adaption and application of the Agency for healthcare Research and Quality’s asthma admission rate pediatric quality indicator to Ohio Medicaid claims data. Res Social Adm Pharma. , 9 3, 240

Guo J, Guo JJ 2013. Ximelagatran and its risk management plan in the United States. . Chinese J Pharmacovigilance , 2, 84-87

Jones JK, Kingery EE, Tao J, Guo JJ*. 2013. Pre-marketing drug safety risk management in the pharmaceutical industry. Chinese J Pharmacoepidemiology. , 22 5 , 1

Lis Y, Roberts MH, Kamble S, Guo JJ, Raisch DW. 2013. Comparison of FDA and EMA Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics & Outcomes Research Risk Management Working Group Value in Health, 15 8, 1108

Tie HT, Xi Y, Zeng YS, Zhang Y, Dai CL, Guo JJ, Zhao Y 2013. Risk of childhood overweight or obesity associated with excessive weight gain during pregnancy: a meta-analysis. Arch Gynecol Obstet , 289 2, 247

Tundia NL, Kelton CML, Cavanaugh TM, Guo JJ, Hanseman DJ, Heaton PC 2013. The effect of Electronic-Medical-Record system sophistication on preventive health care for women. J Am Med Inform Assoc , 20 2, 268-76

Almalki, AZ, Alahmari AK, Guo JJ*, Kelton CML 2012. Access to orphan drug in the Middle East: Challenge and Perspective. Intractable Rare Dis Res , 1 4, 139-143

Bian B, Gorevski E, Kelton CML, Guo JJ. Boone JM. 2012. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam. J Managed Care Pharmacy , 18 7, 506

Desai V, Kelton CML, Guo JJ, Cavanaugh T, Heaton PC. 2012. Drug utilization for antifungal medications in the US Medicaid program from 1991 to 2009. Clin Ther , 34 10, 2118

Gorevski E, Bian B, Kelton CML, Boone JEM, Guo JJ. 2012. Evidence-based prediction of statin use with lipid-panel data from the National Health and Nutrition Examination Survey. Value-in-Health., 15: , 32-

Gorevski E, Bian B, Kelton CML, Boone JM, Guo JJ. 2012. Drug utilization of benzodiapines in the US Medicaid program from 1991 to 2009. Ann Pharmacotherapy , 46 4, 503

Guo J, Kelton CML, Guo JJ. 2012. Recent developments, utilization, and spending trends for Pompe disease therapies. Am Health Drug Benefit , 5 3, 182-

Guo JJ, Kelton CML, Jing Y, Keck PE, Patel N. 2012. Potential drug-drug interaction associated with antipsychotic medications in patients with schizophrenia. Psych Services, 63 11, 1080

Yang BM, Lee K, Chaiyakunapruk N, Guo J. 2012. Widening Horizon of Pharmacoeconomics and Outcomes Research in the Asia-Pacific Region and the Launch of Value-in-Health Regional Issues Value in Health Regional Issues, 1 1, 1

Chiu S, Guo JJ, Wigle PR, Lin A, Szeinbach S 2011. Drug utilization for anti-asthmatic medications in the US Medicaid program Am Health Drug Benefit , 4 3, 140-

Guo JJ, Tsai K, Kelton CML, Bian B, Wigle PR 2011. Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma. Ann Allergy Asthma Immuno, 106 3, 214-

Zhang YJ, Liu WW, Wang JB, Guo JJ. 2011. Potentially inappropriate medication use among elderly population in the US population. Age and Aging, 40 3, 398-

Zhang YJ, Wang YO, Li L, Guo JJ, Wang JB 2011. China’s first rare-disease registry is under development. The Lancet, 378: , 769

Bian B, Kelton CML, Guo JJ*, Wigle PR. 2010. Evaluating safety of long-acting beta agonists (LABAs) in patients with asthma. Current Drug Safety., 5 3, 245-

Bian BB, Guo JJ*, Kelton CML, Wigle PR 2010. Utilization and expenditure trends of ACE inhibitors and ARBs in the Medicaid program. J Managed Care Pharmacy, 16 9, 671-

Bian BB, Guo JJ*, Kelton CML, Wigle PR. 2010. Utilization and expenditure trends of ACE inhibitors and ARBs in the Medicaid program. J Managed Care Pharmacy. , 16 9:, 671-

Guo JJ, Li S, Li X, Lee K, Hu S. 2010. Assessment of Use of Pharmacoeconomics and Outcomes Research in Asia: The ISPOR Asia Consortium Needs Survey Report. ISPOR Connection, 16 1, 11

Guo JJ, Pandey S, Doyle J, Bian B, Raisch D. 2010. A review of current risk-benefit assessments for drug safety. Value in Health. , 13 5, 657

Guo JJ, Wade TJ, Pan W, Keller KN. 2010. School-Based Health Centers: cost-benefit analysis and healthcare disparity. J Am Pub Health Assoc. , 100 5, 1617

Roddy J, Partridge S, Rockey M, Pruemer J, Guo JJ, Desai S, Safa M. 2010. Thromboembolic Events in Patients with Colorectal Cancer Receiving the Combination of Bevacizumab-based Chemotherapy and Erythropoietin Stimulating agents. Am J Clinical Oncology , 33 1, 36

Vaidya S, Guo JJ*, Heaton PC, Steinbuch M. 2010. Comparison of post-marketing drug safety surveillance in some developing countries. Drug Information Journal. , 44 3, 519-

Wade TJ, Guo JJ 2010. Cost-effectiveness analysis for the school-based health centers program. J Am Pub Health Assoc. , 100 5, 1611

Wang JB, Guo JJ**, Yang L, Zhang YD, Sun ZQ, Zhang YJ 2010. Rare diseases and legislation in China. The Lancet , 375: , 708-

Yan WC, Zhang YJ, Guo JJ. 2010. Still some way to go in China: international tobacco control. [commentary] British Medical Journal BMJ, 341: , c6659.

Chen Y, Guo JJ**, Steinbuck M, Buckley PF, Patel C. 2009. Risk of neuroleptic malignant syndrome associated with the use of antipsychotics in patients with bipolar disorder: a retrospective, population-based case-control study. International J Psychiatry Med. , 39 4, 439-

Chen Y, Guo JJ, Li H, Patel NC 2009. Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter? Pharmacoepidemiol Drug Saf , 18 3, 196

Demland J, Jing Y, Kelton CML, Guo JJ, Li H, Wiggle PR 2009. Drug utilization pattern and off-label use of atypical antipsychotics in patients with bipolar disorder: 1998-2002 Am Health Drug Benefit, 2 4, 184

Guo JJ, Kelton CML. 2009. The role of epidemiology for drug development Am Health Drug Benefit. , 2 1 supplement, S49

Chen Y, Guo JJ**, Steinbuck M, Lin XD, Buncher CR, Patel C. 2008. Comparisons of Data Mining Algorithms for Adverse Drug Reactions: An Empirical Study based on the Adverse Event Reporting System of the Food and Drug Administration J Pharm Med , 22 6, 359

Chen Y, Guo JJ, Healy D, Patel NC 2008. Risk of Hepatotoxicity Associated with the Use of Telithromycin: Signal Detection Based upon the FDA’s Spontaneous Reporting System Annals Pharmacotherapy, 42 12:, 1791

Chen Y, Kelton CML, Jing YH, Li X, Guo JJ 2008. Trend analyses of utilization, price, and spending for antidepressant drugs in the US Medicaid program J Res Social Administrative Pharmacy, 4: , 244-257

Guo JJ, Jing Y, Nguyen K, Fan H, Li X, Kelton CM 2008. Principal components analysis of drug utilization and expenditure trends for major therapeutic classes in U.S. Medicaid programs. Journal of Medical Economics, 11: 671-, 694

Guo JJ, Keck PE, Li H, Jang R, Kelton CML 2008. Treatment costs and health utilization for patients with bipolar disorder in a large US managed care population Value in Health, 11 3, 416

Guo JJ, Wade TJ, Keller KN. 2008. Impact of School-Based Health Centers on Students with mental health problems Public Health Reports, 123: 5, 768-80

Kelton CML, Ferrand Y, Heaton PC, Guo JJ. 2008. Impact of health policy on use of antidepressant drug in the US Medicaid program. J Mental Health Policy Economics. , 11 1, 35-

Wade TJ, Keller KN, Guo JJ, Huentelman T, Line K, Mansour ME 2008. Access and utilization patterns across the first three years of implementation of elementary and middle school school-based health centers Public Health Reports, 123 6, 739-750

Chen Y, Guo JJ, Healy D, Zhang S. 2007. Effect of integrated traditional Chinese medicine and Western medicine on SARS treatment: a meta-analysis study Pharmacy Practice, 5 1), 1

Chen Y, Patel NC, Guo JJ, Zhan S. 2007. Antidepressant prophylaxis for poststroke depression: a meta-analysis International Clinical Psychopharmacology, 22 3, 159

Du W, Jing Y, Kelton CML, Guo JJ. 2007. Analysis and comparison of post-marketing surveillance between China and other countries. Value in Health, Suppl. , 11 1, S130

Guo JJ, Keck PE, Li H, Corey-Lisle PK, Jiang DM, Jang R, L’Italien GJ. 2007. Diabetes associated with antipsychotic use among Medicaid patients with bipolar disorders: a nested case-control study Pharmacotherapy , 27 1, 27

Jing Y, Klein P, Kelton CML, Li X, Guo JJ. 2007. Drug price, utilization, and spending of antiretroviral medication in the U.S. Medicaid programs. AIDS Research & Therapy , 4 22, 1-8

Jing YH, Kelton CML, Guo JJ, Chen Y, Li X, Patel NC. 2007. Drug utilization, price, and market-share competition among antipsychotics in US Medicaid programs Drug Benefit Trends, 19 1, 27

Jing YH, Kelton CML, Li X, Guo JJ. 2007. Lethal drug probe in China – a case of Xinfu clindamycin Pharmacoepidemiology Drug Safety, (16) , 928

Kelton CML,Dusing ML, Ferrand Y, Rebelein RP, Guo JJ. 2007. Analysis of Pharmaceutical Products with Large Price Changes in Regional Hospital System J Pharm Fin Econ Policy, 16 2, 61

Li X, Jing Y, Guo JJ. 2007. The reintroduction of natalizumab and its risk management plan Chinese J Pharmacovigilance , 4 1), 14

Chen Y, Guo JJ, Jiang DM, Zhang SY. 2006. Data mining methods for signals of drug adverse reactions [Part 1][Part 2] Chinese Journal of Pharmacoepidemiology , 15 1, 43-46

Guo JJ, Keck PE, Li H, Corey-Lisle PK, et al. 2006. Diabetes mellitus associated with antipsychotic use among patients with bipolar disorders: a population-based case-control study J Clin Psych , 67 7, 1055-1061

Heaton PC, Guo JJ, Cluxton RC, Jang R, Horning R. 2006. Analysis of the effectiveness and cost benefit of leukotriene modifiers in adults with asthma in the Ohio Medicaid population J Manag Care Pharm, 12 1, 33

Jing Y, Li X, Guo JJ. 2006. Drug-induced hepatotoxicity and FDA white papers Chinese Journal of Pharmacovigilance, 3 6, 325

Jing YH, Guo JJ*, Li X. 2006. Pregnancy registry research: FDA Guidance and Case Studies Chinese Journal of Pharmacovigilance, 3 2, 72-80

Jing YH, Kelton CML, Guo JJ*, Chen Y, Li X, Wigle PR. 2006. Price and utilization of HMG Co-A reductase inhibitors (Statins) in the US Medicaid program Drug Benefit Trends , 18 11, 580

Guo JJ, Jang R, Louder A, Cluxton RJ. 2005. Acute Pancreatitis Associated with Different Drug Therapies among HIV-infected Patients Pharmacotherapy, Vol 25 8, 1044-1054

Guo JJ, Wigle R. P, Lammers K, Vu O. 2005. Comparison of Potentially Hepatotoxic Drugs in Major US Drug Compendia J Res Social & Administrative Pharmacy, 8 3, 460-479

Neuss MN, Desch CE, McNiff KK, Eisenberg PD, Guo JJ, et al. 2005. A process for measuring the quality of cancer care: the quality oncology practice initiative (QOPI) J Clin Oncology, 23 25, 6233-9

Guo JJ, Kelton CML, Pasquale MK, Zimmerman J, Patel A, Heaton PC, Cluxton RJ. 2004. Price and Market-Share Competition of Anti-Ulcer Gastric Medications in the Ohio Medicaid Market Int J Pharmaceutical Medicine, Vol.18 5, 271-282.

Liu GG, Guo JJ*, Smith SR. 2004. HIV/AIDS Epidemic and Economic Costs to Business Pharmacoeconomics, Vol.22 18, 1181-1194

Guo JJ, Curkendall S, Jones J, Fife D, Goehring E, She DW. 2003. The impact of cisapride label change on codispending of contraindicated medications J Pharmacoepidemiology Drug Safety, 12, 295-301.

Johnston JA, Cluxton, RJ, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH. 2003. Predictors of Warfarin Use among Ohio Medicaid Patients with New-Onset Nonvalvular Atrial Fibrillation Arch Intern Med , 163, 1705-1710

Jones JK, Fife D, Curkendall S, Guo JJ, et al. 2001. Coprescribing and codispensing of cisapride and contraindicated drugs JAMA-Journal of American Medical Association, 286 13, 1607-1609

Guo JJ, Diehl MC, Felkey BG, Gibson JT, and Barker KN. 1998. Comparison and analysis of the national drug code systems among drug information databases Drug Information Journal, 32 3, 769-775

Guo JJ, Gibson JT, Hancock GR, and Barker KN. 1995. Retrospective drug utilization review and the behavior of Medicaid prescribers: an empirical analysis Clinical Therapeutics, 17 6, 1174-87

Chen Y, Patel NC, Wulsin L, Guo JJ 02-2008. Risk of Cerebral Vascular Diseases associated with antidepressant use in a large managed care population: population-based case-control study Annals Pharmacotherapy, 42 2:, 177